Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Arteriosclerosis Obliterans”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 0 results

Testing effectiveness (Phase 2)UnknownNCT02864654
What this trial is testing

Effectiveness and Safety of Adipose-Derived Regenerative Cells for the Treatment of Critical Lower Limb Ischemia

Who this might be right for
Critical Limb IschemiaArteriosclerosis ObliteransPeripheral Arterial Disease+2 more
Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation 9
Not applicableUnknownNCT04746599
What this trial is testing

Autologous Fat Grafting in the Treatment of Critical Limb Ischaemia

Who this might be right for
Critical Limb IschemiaPeripheral Arterial Disease - PADIschemic Ulcer+5 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 20
Post-approval studies (Phase 4)Study completedNCT00823849
What this trial is testing

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Who this might be right for
Type 2 Diabetes MellitusArteriosclerosis Obliterans
Otsuka Beijing Research Institute 200
Not applicableStudy completedNCT03020290
What this trial is testing

Long Superficial Femoral Artery Stenting With SuperA Interwoven Nitinol Stents

Who this might be right for
Atherosclerosis Obliterans
Nantes University Hospital 335
Testing effectiveness (Phase 2)Study completedNCT01484574
What this trial is testing

A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

Who this might be right for
Critical Limb IschemiaBuerger's Disease
Stempeutics Research Pvt Ltd 90